PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-26 Cr | ₹148 Cr | ₹-37 Cr | ₹-251 Cr | ₹94 Cr |
What is the latest Net Cash Inflow / Outflow ratio of PIRAMAL PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-26 Cr |
| Mar2024 | ₹148 Cr |
| Mar2023 | ₹-37 Cr |
| Mar2022 | ₹-251 Cr |
| Mar2021 | ₹94 Cr |
How is Net Cash Inflow / Outflow of PIRAMAL PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-26 Cr | Negative | |
| Mar2024 | ₹148 Cr | Positive | |
| Mar2023 | ₹-37 Cr | Negative | |
| Mar2022 | ₹-251 Cr | Negative | |
| Mar2021 | ₹94 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,479.0 Cr | 1.1% | -6.1% | -18.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,938.0 Cr | -0.6% | -3.7% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 2.8% | 0.7% | -0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,385.0 Cr | 2.4% | 2.1% | 40.8% | Stock Analytics | |
| CIPLA | ₹111,220.0 Cr | 0.1% | 2.2% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,899.0 Cr | 0.5% | -1.9% | 2.2% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 1.1% |
-6.1% |
-18.8% |
| SENSEX | -1% |
-5% |
-9.2% |
You may also like the below Video Courses